WGS:NSD-GeneDx Holdings Corp. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 77.4

Change

0.00 (0.00)%

Market Cap

USD 2.03B

Volume

0.69M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.37 (+0.47%)

USD 37.81B
HQY HealthEquity Inc

+0.14 (+0.15%)

USD 8.82B
TEM Tempus AI, Inc. Class A Common..

-0.63 (-1.77%)

USD 7.92B
RCM R1 RCM Inc

-2.00 (-4.76%)

USD 6.04B
WAY Waystar Holding Corp. Common S..

+0.11 (+0.30%)

USD 4.47B
BTSG BrightSpring Health Services, ..

+0.13 (+0.75%)

USD 3.18B
PRVA Privia Health Group Inc

-0.16 (-0.80%)

USD 2.52B
OMCL Omnicell Inc

-0.48 (-1.07%)

USD 2.13B
PINC Premier Inc

-0.38 (-1.75%)

USD 2.08B
GDRX Goodrx Holdings Inc

+0.08 (+1.80%)

USD 1.87B

ETFs Containing WGS

XSGI:LSE Xtrackers S&P Global Infr.. 3.68 % 0.00 %

+13.50 (+0.06%)

USD 0.31B
XHS SPDR® S&P Health Care Se.. 3.26 % 0.35 %

-0.09 (0.06%)

USD 0.07B
CPAI Northern Lights Fund Trus.. 2.37 % 0.00 %

+0.02 (+0.06%)

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2,714.55% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,714.55% 100% F 100% F
Trailing 12 Months  
Capital Gain 2,497.32% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,497.32% 100% F 100% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5,082.90% 98% N/A 99% N/A
Dividend Return 5,082.90% 98% N/A 99% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22,587.90% 3% F 1% F
Risk Adjusted Return 22.50% 75% C 55% F
Market Capitalization 2.03B 80% B- 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector